Viewing Study NCT05742594


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-25 @ 11:45 PM
Study NCT ID: NCT05742594
Status: COMPLETED
Last Update Posted: 2023-06-02
First Post: 2023-02-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Four Different Oral Tablet Formulations of Lazertinib (JNJ-73841937) in Healthy Adult Participants
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module